BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 24132589)

  • 1. Significant association between MTHFR C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Sun H; Han B; Zhai H; Cheng X; Ma K
    Tumour Biol; 2014 Jan; 35(1):189-93. PubMed ID: 24132589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of the associations between MTHFR C677T and A1298C polymorphisms and risk of fractures: a meta-analysis.
    Bai R; Liu W; Zhao A; Zhao Z; Jiang D
    Mol Biol Rep; 2013 Mar; 40(3):2419-30. PubMed ID: 23229495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of the association between MTHFR C677T polymorphism and hemorrhagic stroke risk.
    Zhao X; Jiang H
    Mol Biol Rep; 2013 Jan; 40(1):573-8. PubMed ID: 23184002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals.
    Ma C; Liu Y; Zhang W; Liu P
    Mol Biol Rep; 2013 Mar; 40(3):2061-8. PubMed ID: 23329275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis.
    Ding XP; Feng L; Ma L
    Asian Pac J Cancer Prev; 2012; 13(8):3937-42. PubMed ID: 23098496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The polymorphism of methylenetetrahydrofolate reductase C677T but not A1298C contributes to gastric cancer.
    Lv L; Wang P; Sun B; Chen G
    Tumour Biol; 2014 Jan; 35(1):227-37. PubMed ID: 23897558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylenetetrahydrofolate reductase C677T (Ala>Val, rs1801133 C>T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects.
    Zhang S; Jiang J; Tang W; Liu L
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32010931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of the association between MTHFR rs1801131 polymorphism and risk of liver cancer.
    Liang TJ; Liu H; Zhao XQ; Tan YR; Jing K; Qin CY
    Tumour Biol; 2014 Jan; 35(1):339-43. PubMed ID: 24014085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between MTHFR C677T Gene polymorphism with alcohol dependence: A meta-analysis of case-control studies.
    Xu R; Wu H; Zhang S; Zhou H; Liang L
    Neurosci Lett; 2018 Sep; 683():69-74. PubMed ID: 29953924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between MTHFR C677T polymorphism and thyroid cancer risk: a meta-analysis.
    Yan Y; Han F; Fu H; Xia W; Qin X
    Tumour Biol; 2014 Aug; 35(8):7707-12. PubMed ID: 24805831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant association between the MTHFR A1298C polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Chang W; Meng Q; Liu JH; Wu LX; Chen Y; Chen SD
    Genet Mol Res; 2015 Dec; 14(4):15972-80. PubMed ID: 26662389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the maternal MTHFR C677T polymorphism with susceptibility to neural tube defects in offsprings: evidence from 25 case-control studies.
    Yan L; Zhao L; Long Y; Zou P; Ji G; Gu A; Zhao P
    PLoS One; 2012; 7(10):e41689. PubMed ID: 23056169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between methylenetetrahydrofolate reductase C677T polymorphism and epilepsy susceptibility: a meta-analysis.
    Wu YL; Yang HY; Ding XX; Zhao X; Chen J; Bi P; Sun YH
    Seizure; 2014 Jun; 23(6):411-6. PubMed ID: 24556013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the MTHFR C677T polymorphism with primary brain tumor risk.
    Xu C; Yuan L; Tian H; Cao H; Chen S
    Tumour Biol; 2013 Dec; 34(6):3457-64. PubMed ID: 23846816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk in Chinese population.
    Qi X; Sun X; Xu J; Wang Z; Zhang J; Peng Z
    Tumour Biol; 2014 Mar; 35(3):1757-62. PubMed ID: 24385382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study between methylenetetrahydrofolate reductase polymorphisms and unexplained recurrent pregnancy loss: a meta-analysis.
    Cao Y; Xu J; Zhang Z; Huang X; Zhang A; Wang J; Zheng Q; Fu L; Du J
    Gene; 2013 Feb; 514(2):105-11. PubMed ID: 23201418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphism of MTHFR C677T with preterm birth and low birth weight susceptibility: a meta-analysis.
    Wu H; Zhu P; Geng X; Liu Z; Cui L; Gao Z; Jiang B; Yang L
    Arch Gynecol Obstet; 2017 May; 295(5):1105-1118. PubMed ID: 28283826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between MTHFR C677T Polymorphism and Risk of Prostate Cancer: Evidence from 22 Studies with 10,832 Cases and 11,993 Controls.
    Abedinzadeh M; Zare-Shehneh M; Neamatzadeh H; Abedinzadeh M; Karami H
    Asian Pac J Cancer Prev; 2015; 16(11):4525-30. PubMed ID: 26107198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between MTHFR gene polymorphisms (C677T, A1298C) and genetic susceptibility to prostate cancer: a meta-analysis.
    Chen PL; Li WT; Wang J; Jiang YD; Wu P; Chen T; Zheng SB
    Genet Mol Res; 2015 Dec; 14(4):19191-202. PubMed ID: 26782572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MTHFR C677T polymorphism and osteoporotic fracture in postmenopausal women: a meta-analysis.
    Guan JZ; Wu M; Xiao YZ; Zhou JS; Wang ZD
    Genet Mol Res; 2014 Sep; 13(3):7356-64. PubMed ID: 25222234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.